SNC-Lavalin Group Inc. (TSE:ATR – Free Report) – Investment analysts at Raymond James dropped their Q1 2025 earnings per share (EPS) estimates for shares of SNC-Lavalin Group in a report released on Friday, March 14th. Raymond James analyst F. Bastien now anticipates that the company will post earnings per share of $0.54 for the quarter, down from their previous estimate of $0.57. Raymond James also issued estimates for SNC-Lavalin Group’s Q2 2025 earnings at $0.65 EPS, Q4 2025 earnings at $0.82 EPS, Q1 2026 earnings at $0.70 EPS, Q2 2026 earnings at $0.84 EPS, Q3 2026 earnings at $1.01 EPS and Q4 2026 earnings at $0.85 EPS.
Separately, Stifel Canada upgraded SNC-Lavalin Group to a “strong-buy” rating in a research report on Tuesday, February 4th.
SNC-Lavalin Group Stock Performance
About SNC-Lavalin Group
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
Read More
- Five stocks we like better than SNC-Lavalin Group
- How to Use Stock Screeners to Find Stocks
- Can TikTok Stock Picks Really Make You Rich?
- What Investors Need to Know to Beat the Market
- The “Quality” Rotation: Back to Basics Investing
- How to Capture the Benefits of Dividend Increases
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for SNC-Lavalin Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SNC-Lavalin Group and related companies with MarketBeat.com's FREE daily email newsletter.
